CLINICAL_TRIALS
trial_result
· 2023-04-26
Clinical Trial Update: A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating sulforaphane in schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Central South University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED